Deutsch English Français

Contact

EP2380024

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2380024

EP2380024 - ARMET AS A MARKER FOR CANCER [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.04.2015 Database last updated on 05.10.2024
Most recent event Tooltip	22.06.2018	Lapse of the patent in a contracting state New state(s): MK	published on 25.07.2018 [2018/30]
Applicant(s)	For:DE Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE
	For:AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR F. Hoffmann-La Roche AG Grenzacherstraße 124 4070 Basel / CH
	[N/P]
Former [2011/43]	For:DE Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim / DE
	For:AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
Inventor(s)	01 / ROESSLER, Markus Eichenstrasse 9a 82110 Germering / DE
	02 / KARL, Johann Bert-Schratzlseer-Strasse 7 82380 Peissenberg / DE
	03 / * * *
	04 / * * *
	05 / TACKE, Michael Geisenfelder Strasse 7 80689 München / DE
	[2014/21]
Former [2011/43]	01 / ROESSLER, Markus Eichenstrasse 9a 82110 Germering / DE
	02 / KARL, Johann Bert-Schratzlseer-Strasse 7 82380 Peissenberg / DE
	03 / RIEDLINGER, Julia Kleinstrasse 3 81379 München / DE
	04 / LINDNER, Ingo Herzogstandstrasse 3 82377 Penzberg / DE
	05 / TACKE, Michael Geisenfelder Strasse 7 80689 München / DE
Representative(s)	Burger, Alexander Roche Diagnostics GmbH Patentabteilung Nonnenwald 2 82377 Penzberg / DE
	[N/P]
Former [2011/43]	Burger, Alexander Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52 82372 Penzberg / DE
Application number, filing date	09798890.1	18.12.2009
	WO2009EP09159
Priority number, date	EP20080022238	22.12.2008 Original published format: EP 08022238
	[2011/43]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2010072383
	Date:	01.07.2010
	Language:	EN
	[2010/26]
	Type:	A1 Application with search report
	No.:	EP2380024
	Date:	26.10.2011
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 01.07.2010 takes the place of the publication of the European patent application.
	[2011/43]
	Type:	B1 Patent specification
	No.:	EP2380024
	Date:	11.06.2014
	Language:	EN
	[2014/24]
Search report(s)	International search report - published on:	EP	01.07.2010
Classification	IPC:	G01N33/574	[2011/43]
	CPC:	G01N33/57484 (EP,US); G01N33/57488 (US); G01N33/57423 (EP,US); G01N2333/475 (US); G01N2800/52 (US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2014/24]
Extension states	AL	Not yet paid
	BA	Not yet paid
	RS	Not yet paid
Title	German:	ARMET ALS KREBSMARKER	[2013/24]
	English:	ARMET AS A MARKER FOR CANCER	[2011/43]
	French:	ARMET EN TANT QUE MARQUEUR POUR CANCER	[2014/24]
	Former [2011/43]	ARMET ALS MARKER FÜR KREBS
	Former [2011/43]	ARMET EN TANT QUE MARQUEUR DU CANCER
Entry into regional phase	22.07.2011	National basic fee paid
	22.07.2011	Designation fee(s) paid
	22.07.2011	Examination fee paid
Examination procedure	18.10.2010	Request for preliminary examination filed International Preliminary Examining Authority: EP
	22.07.2011	Examination requested [2011/43]
	13.01.2012	Amendment by applicant (claims and/or description)
	23.11.2012	Despatch of a communication from the examining division (Time limit: M03)
	18.12.2012	Reply to a communication from the examining division
	28.05.2013	Communication of intention to grant the patent
	23.08.2013	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	14.11.2013	Communication of intention to grant the patent
	06.02.2014	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	27.03.2014	Communication of intention to grant the patent
	28.04.2014	Fee for grant paid
	28.04.2014	Fee for publishing/printing paid
	28.04.2014	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.11.2012
Opposition(s)	12.03.2015	No opposition filed within time limit [2015/21]
Fees paid	Renewal fee
	07.12.2011	Renewal fee patent year 03
	07.12.2012	Renewal fee patent year 04
	06.12.2013	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	18.12.2009
	BE	11.06.2014
	BG	11.06.2014
	CY	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	GR	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	MK	11.06.2014
	MT	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	TR	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
	[2018/30]
Former [2016/33]	HU	18.12.2009
	BE	11.06.2014
	BG	11.06.2014
	CY	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	GR	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	MT	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	TR	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2016/32]	HU	18.12.2009
	BE	11.06.2014
	BG	11.06.2014
	CY	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	GR	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	TR	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2016/31]	BE	11.06.2014
	BG	11.06.2014
	CY	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	GR	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2016/28]	BE	11.06.2014
	BG	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2016/27]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	MC	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2016/22]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	SM	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2015/46]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	IE	18.12.2014
	LU	18.12.2014
Former [2015/36]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SI	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	LU	18.12.2014
Former [2015/35]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
	LU	18.12.2014
Former [2015/30]	BE	11.06.2014
	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
Former [2015/22]	CZ	11.06.2014
	DK	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
Former [2015/12]	CZ	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	NL	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	IS	11.10.2014
	PT	13.10.2014
Former [2015/11]	CZ	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	PL	11.06.2014
	RO	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
	PT	13.10.2014
Former [2015/10]	CZ	11.06.2014
	EE	11.06.2014
	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	SE	11.06.2014
	SK	11.06.2014
	NO	11.09.2014
Former [2014/50]	FI	11.06.2014
	HR	11.06.2014
	LT	11.06.2014
	LV	11.06.2014
	SE	11.06.2014
	NO	11.09.2014
Former [2014/49]	FI	11.06.2014
	LT	11.06.2014
	NO	11.09.2014
Former [2014/48]	LT	11.06.2014
Cited in	International search	[A]WO2004108964 (AGENCY SCIENCE TECH & RES [SG], et al) [A] 1-7 * the whole document * * In particular: p. 1, l. 8-31; p. 11, l. 4-9 and Fig. 7c; Table 1, p. 37; Table 3, p. 59; claims 9-17. *;
		[A] - SHRIDHAR V ET AL, "A GENE FROM HUMAN CHROMOSOMAL BAND 3P21.1 ENCODES A HIGHLY CONSERVED ARGININE-RICH PROTEIN AND IS MUTATED IN RENAL CELL CARCINOMAS", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, (19960502), vol. 12, no. 9, ISSN 0950-9232, pages 1931 - 1938, XP002906046 [A] 17 * the whole document * * In particular: Title and Abstract. *
		[X] - SHRIDHAR RAVI ET AL, "Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck", CANCER RESEARCH, (1996), vol. 56, no. 24, ISSN 0008-5472, pages 5576 - 5578, XP002522438 [X] 1-7 * the whole document * * In particular: title, abstract, materials and methods and Results section. *
		[A] - PIEPOLI ADA ET AL, "Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients.", WORLD JOURNAL OF GASTROENTEROLOGY : WJG 21 OCT 2006, (20061021), vol. 12, no. 39, ISSN 1007-9327, pages 6343 - 6348, XP002522439 [A] 1-7 * the whole document * * In particular: Title and abstract. *
		[A] - SHRIDHAR VIJI ET AL, "Mutations in the arginine-rich protein gene (ARP) in pancreatic cancer", ONCOGENE, (1997), vol. 14, no. 18, ISSN 0950-9232, pages 2213 - 2216, XP002522440 [A] 1-7 * the whole document * * In particular: title and abstract;Table 1 and Fig. 1. * DOI: http://dx.doi.org/10.1038/sj.onc.1201054
		[A] - DRACH JOHANNES ET AL, "A cellular proteome map of human multiple myeloma", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200711), Database accession no. PREV200800215384, XP002522442 [A] 1-7 * the whole document *
		[ ] - BLOOD, 49TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 08 -11, 2007, (200711), vol. 110, no. 11, Part 1, ISSN 0006-4971, page 41A
		[A] - MIZOBUCHI NAOMI ET AL, "ARMET is a soluble ER protein induced by the unfolded protein response via ERSE-II element", CELL STRUCTURE AND FUNCTION, (2007), vol. 32, no. 1, ISSN 0386-7196, pages 41 - 50, XP002522441 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1247/csf.07001
	by applicant	WO2004057336
		- DUFFY, M.J., CRIT. REV. CLIN. LAB. SCI., (2001), vol. 38, pages 225 - 262
		- AKSOY, S. ET AL., J. BIOL. CHEM., (1994), vol. 269, pages 14835 - 14840
		- OKAMURA, A. ET AL., JPN. J. CANCER RES., (1998), vol. 89, pages 649 - 656
		- KASSEM, H. ET AL., INT. J. CANCER, (2002), vol. 101, pages 454 - 460
		- SCHNEIDER, J. ET AL., INT. J. CLIN. ONCOL., (2002), vol. 7, pages 145 - 151
		- SHRIDHAR, V. ET AL., ONCOGENE, (1996), vol. 12, pages 1931 - 1939
		- SHRIDHAR, R. ET AL., CANCER RES., (1996), vol. 56, pages 5576 - 5578
		- SHRIDHAR, V. ET AL., ONCOGENE, (1997), vol. 14, pages 2213 - 2216
		- TANAKA, H. ET AL., ONCOL. REP., (2000), vol. 7, pages 591 - 593
		- MIZOBUCHI, N. ET AL., CELL STRUCT. FUNCT., (2007), vol. 32, pages 41 - 50
		- PETROVA, P. ET AL., J. MOL. NEUROSCI., (2003), vol. 20, pages 173 - 188
		- TANAKA, H. ET AL., ONCOL. REP, (2000), vol. 7, pages 591 - 593
		- APOSTOLOU, A. ET AL., EXP. CELL RES., (2008), vol. 314, pages 2454 - 2467
		- MOLINA, R. ET AL., TUMOR BIOL., (2003), vol. 24, pages 209 - 218
		- MERLE, P. ET AL., INT. J. OF BIOLOGICAL MARKERS, (2004), vol. 19, pages 310 - 315
		- FUKASAWA, T. ET AL., CANCER & CHEMOTHERAPY, (1986), vol. 13, pages 1862 - 1867
		- WAGNER, H. JR., CHEST, (2000), vol. 117, pages 5110 - 5118
		- BUCCHERI, G. ET AL., ANN. THORAC. SURG., (2003), vol. 75, pages 973 - 980
		- RUCZINSKI, I. ET AL., J. OF COMPUTATIONAL AND GRAPHICAL STATISTICS, (2003), vol. 12, pages 475 - 511
		- FRIEDMAN, J. H., J. OF THE AMERICAN STATISTICAL ASSOCIATION, (1989), vol. 84, pages 165 - 175
		- BREIMAN, L.; RANDOM FORESTS, MACHINE LEARNING, (2001), vol. 45, pages 5 - 32
		- PEPE, M.S., The Statistical Evaluation of Medical Tests for Classification and Prediction, OXFORD STATISTICAL SCIENCE SERIES, (2003), vol. 28
		- ZWEIG, M.H.; CAMPBELL, G., CLIN. CHEM., (1993), vol. 39, pages 561 - 577

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p